title: Angiotensin II reduces transport-dependent oxygen consumption but increases transport-independent oxygen consumption in immortalized mouse proximal tubular cells.
abstract: Oxidative stress is closely associated with renal dysfunction following diabetes and hypertension. Angiotensin II (Ang II) can activate the NADPH-oxidase, increasing oxidative stress that is thought to blunt proximal tubular electrolyte transport and thereby oxygen consumption (QO₂). We investigated the effect of Ang II on QO₂ in immortalized mouse proximal tubular cells over-expressing the NADPH oxidase subunit p22(phox); a model of increased oxidative stress. Cultured cells were exposed to either Ang II or H₂O₂ for 48 h. QO₂ was determined during baseline (113 mmol/l NaCl; transport-dependent QO₂) and during sodium-free conditions (transport-independent QO₂). Ang II reduced transport-dependent QO₂ in wild-types, but not in p22(phox) which also displayed increased QO₂ at baseline. Transport-independent QO₂ was increased in p22(phox) and Ang II had no additional effect, whereas it increased QO₂ in wild-type. Addition of H₂O₂ reduced transport-dependent QO₂ in wild-types, but not in p22(phox). Transport-independent QO₂ was unaffected by H₂O₂. The similar effects of Ang II and H₂O₂ to reduce transport-dependent QO₂ suggest a direct regulatory role of oxidative stress. In accordance, the transport-dependent QO₂ was reduced in p22(phox) already during baseline. The effects of Ang II on transport-independent QO₂ was not replicated by H₂O₂, indicating direct regulation via Ang II-receptors independently of oxidative stress. However, the Ang II effect was absent in p22(phox), suggesting that oxidative stress also modulates normal Ang II signaling. In conclusion, Ang II affects both transport-dependent and transport-independent QO₂ in proximal tubular cells and may be an important pathway modulating renal QO₂.
authors.affiliation: Department of Medical Cell Biology, Uppsala University, Biomedical Center, Husargatan 3, Uppsala, 751 23, Sweden. Malou.Friederich@mcb.uu.se.
authors.forename: Malou
authors.initials: M
authors.lastname: Friederich-Persson
authors.affiliation: Department of Medicine, Georgetown University Medical Center, Washington DC, USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Welch
authors.affiliation: Department of Medicine, Georgetown University Medical Center, Washington DC, USA.
authors.forename: Zaiming
authors.initials: Z
authors.lastname: Luo
authors.affiliation: Department of Medical Cell Biology, Uppsala University, Biomedical Center, Husargatan 3, Uppsala, 751 23, Sweden.|Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.|Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.
authors.forename: Fredrik
authors.initials: F
authors.lastname: Palm
authors.affiliation: Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
authors.forename: Lina
authors.initials: L
authors.lastname: Nordquist
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002461:Cell Line, Transformed; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D018384:Oxidative Stress; D010101:Oxygen Consumption / Q000187:drug effects*
chemical_list: D000804:Angiotensin II
references.citation: Kidney Int. 2005 Aug;68(2):723-30
references.pmid: 16014049
references.citation: Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2234-40
references.pmid: 11045958
references.citation: J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S149-61
references.pmid: 9892156
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Jun;290(6):R1616-25
references.pmid: 16410402
references.citation: J Am Soc Nephrol. 2005 Mar;16(3):703-11
references.pmid: 15647337
references.citation: J Biol Chem. 2002 Dec 6;277(49):47129-35
references.pmid: 12372827
references.citation: Circ Res. 2008 Feb 29;102(4):488-96
references.pmid: 18096818
references.citation: Acta Physiol Scand. 1961 Apr;51:371-84
references.pmid: 13759307
references.citation: Diabetes. 1994 May;43(5):629-33
references.pmid: 8168637
references.citation: Curr Hypertens Rep. 2000 Feb;2(1):98-105
references.pmid: 10981135
references.citation: Pharmacol Rev. 2007 Sep;59(3):251-87
references.pmid: 17878513
references.citation: Diabetologia. 2003 Aug;46(8):1153-60
references.pmid: 12879251
references.citation: Hypertension. 2008 Dec;52(6):1091-8
references.pmid: 19001187
references.citation: Hypertension. 2002 Feb;39(2):269-74
references.pmid: 11847196
references.citation: Kidney Int. 2003 Jan;63(1):202-8
references.pmid: 12472784
references.citation: Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14849-54
references.pmid: 21852574
references.citation: Diabetologia. 2012 May;55(5):1535-43
references.pmid: 22311417
references.citation: Nature. 2002 Jan 3;415(6867):96-9
references.pmid: 11780125
references.citation: Hypertension. 2002 Oct;40(4):511-5
references.pmid: 12364355
references.citation: Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):935-40
references.pmid: 18439413
references.citation: Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H22-8
references.pmid: 15598867
references.citation: Hypertens Res. 2008 Feb;31(2):305-13
references.pmid: 18360051
references.citation: Free Radic Res Commun. 1993;19(1):59-66
references.pmid: 8225035
references.citation: J Am Soc Nephrol. 2006 Jan;17(1):17-25
references.pmid: 16291837
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Jul;285(1):R117-24
references.pmid: 12609817
references.citation: Circ Res. 2001 Aug 31;89(5):408-14
references.pmid: 11532901